Research Associate Scientist II
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Dr. Osheiza Abdulmalik. Research Associate Scientist, The Children's Hospital of Philadelphia.
Dr. Abdulmalik’s research interests involve hemoglobinopathies and red blood cell disorders, with a focus on sickle cell disease and beta-thalassemia. Primary Research in the Abdulmalik Lab at the Children's Hospital of Philadelphia focuses on the design, development, and investigation of small molecules targeting sickle hemoglobin and disrupting the polymerization that underlays the primary pathophysiology of SCD. On this theme, Dr. Abdulmalik maintains ongoing, highly productive drug-development collaborations with an array of academic and industry investigators/partners to de novo design and investigate small molecules that can potentially benefit patients with SCD.
Disclosure information not submitted.
ILX-002 – A Direct HbS Polymerization Inhibitor for the Treatment of Sickle Cell Disease
Saturday, June 8, 2024
6:00 PM – 7:00 PM ET